FDA COVID Update Expanding Use of Pfizer Vaccine

January 03, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to: Expand the use of a single booster dose to include use in individuals12 through 15 years of age. Shorten the time between the completion of

Read more